Please login to the form below

Not currently logged in
Email:
Password:

American Diabetes Association

This page shows the latest American Diabetes Association news and features for those working in and with pharma, biotech and healthcare.

J&J says real-world data finds no amputation risk for Invokana

J&J says real-world data finds no amputation risk for Invokana

A year ago, regulators slapped warnings to the labelling for Johnson &Johnson’s diabetes drug Invokana, setting it at a disadvantage against rival drugs in the SGLT2 inhibitor class, but now ... Now, J&J has data from a patient registry involving more

Latest news

More from news
Approximately 2 fully matching, plus 61 partially matching documents found.

Latest Intelligence

  • Interview: Phil Southerland, Team Novo Nordisk Interview: Phil Southerland, Team Novo Nordisk

    It hit home at the American Diabetes Association conference this year, where I had a number of colleagues who said how much it meant to them how we were all type ... 1. It was proof that anything is possible even if you have diabetes.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics